ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lenalidomid Sandoz 2.5 mg, Kapseln - 21
67456010 Sandoz Pharmaceuticals AG
Lenalidomid Sandoz 2.5 mg, Kapseln05.05.2020
  05.05.2020
Lenalidomide (L04AX04) 
WHO-DDD04.05.2025
07.16.10.21
07.16.40. 
A  
No 
 CI
PR  
k.A.PR
  
7680674560104Synthetika
  
Composition
lenalidomidum 2.5 mg, cellulosum microcristallinum, lactosum 33.2 mg, carmellosum natricum conexum corresp. natrium 0.089 mg, magnesii stearas, gelatina, E 171, E 172 (flavum), E 132, lacca, Drucktinte: E 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Lenalidomidum2.5 mg
BAG: Active AgentDose
Lenalidomidum2.5 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 132 color.
E 171 color.
E 172 Drucktinte
Gelatina  
Kalii Hydroxidum  
Lacca  
Lactosum33.2 mg 
Magnesii Stearas  
Pro Capsula  
Propylenglycol  
 
Source
Data was imported : 06.08.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home